Insider · SEC Form 4 filer
Robert Wills
Companies
Where they file as an insider
Alpha Cognition (ACOG) Director Latest filing Aug 21, 2026
Milestone Pharmaceuticals (MIST) Director Latest filing Jul 11, 2025
Oncternal Therapeutics (ONCT) Director Latest filing Apr 8, 2024
CymaBay Therapeutics (CBAY) Director Latest filing Mar 22, 2024
Track record
Did their buys beat the typical stock?
Open-market buys4
Quarters checked 6 months later1
Beat the typical stock —
Quarters too new to check1
Too soon to tell. 1 quarter has finished so far. We show a record once 3 have.
Alpha Cognition (ACOG) Bought Aug 21, 2026 · $96.2K · 10,000 shares Too new Too new. Its 6-month check uses prices as of Mar 31, 2027.
Alpha Cognition (ACOG) Bought Aug 18, 2025 · $127K · 15,000 shares Behind typical Sep 30, 2025 $6.51 → Mar 31, 2026 $5.49 · −15.7% (typical stock −3.4%)
Oncternal Therapeutics (ONCT) Bought Apr 8, 2024 · $27.7K · 3,086 shares Not counted Not counted. We have no fund price for this stock on both Jun 30, 2024 and Dec 31, 2024.
Oncternal Therapeutics (ONCT) Bought Mar 28, 2024 · $58.6K · 6,914 shares Not counted Not counted. We have no fund price for this stock on both Mar 31, 2024 and Sep 30, 2024.
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.